Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism 5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H18ClNO |
InChIKeyKTBSRSVHEOTHLD-DDOUFSBJSA-N |
CAS Registry148834-81-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Prostatic Hyperplasia | Preclinical | US | 01 Jan 1994 |